Abingdon Health (LON:ABDX) Stock Price Down 4.7% – Here’s What Happened

Shares of Abingdon Health Plc (LON:ABDX) dropped 4.7% during mid-day trading on Wednesday . The company traded as low as GBX 9 and last traded at GBX 10. Approximately 668,528 shares changed hands during mid-day trading, an increase of 195% from the average daily volume of 226,756 shares. The stock had previously closed at GBX 10.49.

Abingdon Health Stock Down 2.9%

The company has a market capitalization of £23.15 million, a PE ratio of -11.38 and a beta of 0.25. The company has a quick ratio of 1.96, a current ratio of 1.91 and a debt-to-equity ratio of 15.05. The firm has a 50-day moving average of GBX 7.77 and a two-hundred day moving average of GBX 6.95.

Abingdon Health (LON:ABDX) last issued its quarterly earnings data on Tuesday, March 17th. The company reported GBX (0.43) earnings per share for the quarter. Abingdon Health had a negative return on equity of 55.91% and a negative net margin of 33.88%.

About Abingdon Health

Abingdon Health is a world leading contract developer and manufacturer (CDMO) of high-quality rapid tests across all industry sectors, including healthcare, infectious disease, animal health, environmental and self-testing. Abingdon is the partner of choice for a growing global customer base and takes projects from initial concept through to routine and large-scale manufacturing and regulatory approval. The Company also markets its own range of self-tests under the Abingdon Simply Test brand (www.abingdonsimplytest.com) and has developed and marketed its own labelled tests.